Thrombotic thrombocytopenic purpura natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Thrombotic thrombocytopenic purpura}} {{CMG}} ==Overview== ==Prognosis== The mortality rate is approximately 95% for untreated cases, but the prognosis is reasonab...") |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
==Natural History== | |||
==Complications== | |||
==Prognosis== | ==Prognosis== | ||
The mortality rate is approximately 95% for untreated cases, but the prognosis is reasonably favorable (80-90%) for patients with idiopathic TTP diagnosed and treated early with plasmapheresis. | The mortality rate is approximately 95% for untreated cases, but the prognosis is reasonably favorable (80-90%) for patients with idiopathic TTP diagnosed and treated early with plasmapheresis. |
Revision as of 14:59, 21 September 2012
Thrombotic thrombocytopenic purpura Microchapters |
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura natural history, complications and prognosis |
FDA on Thrombotic thrombocytopenic purpura natural history, complications and prognosis |
CDC on Thrombotic thrombocytopenic purpura natural history, complications and prognosis |
Thrombotic thrombocytopenic purpura natural history, complications and prognosis in the news |
Blogs on Thrombotic thrombocytopenic purpura natural history, complications and prognosis |
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Natural History
Complications
Prognosis
The mortality rate is approximately 95% for untreated cases, but the prognosis is reasonably favorable (80-90%) for patients with idiopathic TTP diagnosed and treated early with plasmapheresis.
Approximately one-third of patients experiencing a TTP episode have a relapse within 10 years following their first attack.
Secondary TTP still has a dismal prognosis, with mortality rates despite treatment being reported as 59% to 100%.